MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar.

Production & Packing (OSD ) Dept - Formulation Division

Post : Officer | Jr. Executive | Executive | Sr. Executive

Synergene Active Ingredients Pvt. Ltd., incorporated in 2006, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of therapeutic categories. The therapeutic segments of focus are Anti-Fungal, Anti-Depressant, Anti-Migraine. Anti-Glaucoma, Anti-Hypertensive, Analgesic, Anti-Histaminic, Antibiotic, Premature Ejaculation and Nootropic.

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base.

Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.

The study was published today in Pediatrics.
Researchers examined data from 218 children across the state of Texas between the ages of 5 and 19 who were enrolled in the Texas CARES survey, which began in October of 2020 with the goal of assessing COVID-19 antibody status over time among a population of adults and children in Texas.

A study has found that much higher doses of antibiotics are needed to eliminate a bacterial infection of the airways when other microbes are present. It helps explain why respiratory infections often persist in people with lung diseases such as cystic fibrosis despite treatment.

Bharat Biotech has entered into a partnership with Biofabri, a Spanish biopharmaceutical firm, for the development, manufacturing and marketing of a new tuberculosis vaccine. This partnership will guarantee the supply of TB vaccines in more than 70 countries especially in Southeast Asia, and sub-Saharan Africa with a high TB incidence.

India has a high burden of Tuberculosis, recording close to 2.64 million cases and 75,000 plus deaths in 2019. A considerable percentage of these cases come from underdeveloped, remote areas without proper access to healthcare services. It is a huge challenge to triage, screen, and monitor it promptly, and at scale, with minimal resources.

Granules India ltd has received a license from Medicines Patent Pool (MPP) to manufacture and market generic versions of Pfizer’s oral treatment nirmatrelvir which will be copackaged with ritonavir for treatment of COVID-19. The licenses are applicable for both active pharmaceutical ingredients (API) and finished products, in tablet form, of nirmatrelvir; ritonavir.

Granules India Limited, announced that Granules Pharmaceuticals, Inc. (GPI), a wholly-owned foreign subsidiary of the company, located in Chantilly, Virginia, USA received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA).

The GPI facility was inspected by the US FDA from 24th to 28th January 2022 for two of its product applications filed. There were three minor observations during the inspection and GPI had addressed the observations in the stipulated time period.

Established in 1984, the Institute of Microbial Technology (IMTech) is one among the chain of 37 national laboratories, 6 units and 39 outreach centres of the Council of Scientific and Industrial Research. Set-up to be a fore-runner in the niche domain of microbial biotechnology, the Institute in its initial years functioned from a start-up laboratory that provided a truly world-class R&D ambience in an area of over 10,000 sq. ft. to its researchers.

Jawaharlal Nehru University is the foremost university in India, and a world-renowned centre for teaching and research. Ranked number one in India by the National Assessment and Accreditation Council (NAAC) with a Grade Point of 3.91 (on a scale of 4), JNU was ranked no 3 among all universities in India by the National Institutional Ranking Framework, Government of India, in 2016 and no 2 in 2017. JNU also received the Best University Award from the President of India in 2017.

Translational Health Science and Technology Institute is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt, of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conduct innovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post: Research Fellow, Project Assistant

WHO is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends.

Post : Roster for Consultants – Health Technology - (2201849)

Piramal Healthcare Limited A major force in the pharmaceuticals and healthcare segment, Piramal Healthcare Limited, incorporating Healthcare Solutions & Pharma Solutions, has an unequivocal vision – to become the most admired pharmaceutical company, with leadership in market share and profits.

Post : Research Scientist - (220000X8)

Teva is a global pharmaceutical leader and the worlds largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. Our employees are at the core of our success, with colleagues in over 80 countries delivering the world's largest medicine cabinet to 200 million people every day.

Post : Regulatory Affairs Associate I - Submission Publishing

Phamax is a Swiss headquartered independent healthcare consulting firm. At phamax we provide analytics support to our clients in the healthcare space. Our team of domain experts, data specialists and physicians works as a Wingman, empowering our customers to focus on what is really important. We deliver our services across the world, covering all aspects of commercial, scientific and digital analytics. Our new technology solution wing is working on conversational AI digital assistant, Ariya to empower healthcare organizations to simplify information processes.

Dano Vaccines & Biologicals Pvt Ltd has been involved in manufacturing and distribution of vaccines for the past 36 years. We are proud to be one of the largest manufacturers of Tetanus Toxoid (T.T) Vaccine in India by the number of doses produced.

The Central Government Health Scheme was started in 1954 with the objective of providing comprehensive medical care to the Central Government employees, both serving and pensioners and their dependent family members. The scheme is also providing service to members and former members of parliament, judges of Supreme Court and High Court, freedom fighters, former Governors and former Vice-Presidents of India.

Post : Pharmacist (Allopathy)